Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24% By Reuters
Breaking News
‘;
Published Mar 18, 2024 07:09
Updated Mar 18, 2024 08:25
© Reuters. FILE PHOTO: The company logo for Haleon and the trading info is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2022. REUTERS/Brendan McDermid/File Photo
(Reuters) -Consumer healthcare firm Haleon (LON:HLN) said on Monday that U.S. drugmaker Pfizer (NYSE:PFE), its top shareholder, will sell down its stake in the company to about 24%.
Pfizer, which currently holds a 32% stake in Haleon, said last year it planned to cut its ownership in a “slow and methodical” manner within months.
The offer price per share is expected to be announced on or around March 19, following the completion of a book-building process, Haleon said in a statement.
The sale of 630 million shares would be worth about 2.03 billion pounds ($2.58 billion), according to Haleon’s Friday closing price.
Shares in the FTSE 100-listed company dropped 2.2% to 315 pence in early trading on Monday.
Haleon, which makes household brands such as Sensodyne toothpaste and Advil painkillers, was spun out of British drugmaker GSK (LON:GSK) in July 2022. It was formed in 2019 by merging GSK and Pfizer’s consumer healthcare businesses.
GSK has since sold down its stake in the company, with the last sale in January bringing down its shareholding to 4.2% from the 12.9% it initially retained in the business. It is Haleon’s second-largest shareholder.
Haleon will also repurchase shares worth about 315 million pounds from Pfizer off-market, it said on Monday.
The London-listed company last month announced plans to buy back 500 million pounds of its shares this year amid firm demand for its products and progress in reducing debt.
Former parent GSK has also benefited from the spin-off, beating quarterly estimates and delivering an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and cancer drugs pipeline.
($1 = 0.7854 pounds)
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
Most Popular Articles
Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information
© 2007-2024 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Comments